Clonidine and Microangiopathy - a phase IV clinical study of FDA data
Summary:
Microangiopathy is reported as a side effect among people who take Clonidine (clonidine), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Cozaar, and have Cataplexy.
The phase IV clinical study analyzes which people have Microangiopathy when taking Clonidine. It is created by eHealthMe based on reports of 63,883 people who have side effects when taking Clonidine from the FDA, and is updated regularly.
What is Clonidine?
Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 65,645 Clonidine users. Check the latest studies of Clonidine.
What is Microangiopathy?
Microangiopathy (disease of the capillaries (very small blood vessels), in which the capillary walls become so thick and weak that they bleed, leak protein) is found to be associated with 234 drugs and 332 conditions by eHealthMe. Check the latest studies of Microangiopathy.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
63,883 people reported to have side effects when taking Clonidine.
Among them, 11 people (0.02%) have Microangiopathy.

Among these 11 people:
How long have people been on Clonidine when they have Microangiopathy? *
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Microangiopathy when taking Clonidine? *
- female: 81.82 %
- male: 18.18 %
What is the age of people who have Microangiopathy when taking Clonidine? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 33.33 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 66.67 %
What are other drugs people take besides Clonidine? *
- Cozaar: 7 people, 63.64%
- Zocor: 6 people, 54.55%
- Livalo: 5 people, 45.45%
- Cartia Xt: 5 people, 45.45%
- Nasacort: 5 people, 45.45%
- Valium: 5 people, 45.45%
- Zomig: 5 people, 45.45%
- Amlodipine: 5 people, 45.45%
- Lasix: 5 people, 45.45%
- Xyrem: 5 people, 45.45%
What are other side effects people have besides Microangiopathy? *
- Pernicious Anaemia (anaemia due to lack of vitamin b12): 5 people, 45.45%
- Drug Ineffective: 5 people, 45.45%
- Colitis Ischaemic (due to infection of intestine impaired blood supply to colon): 5 people, 45.45%
- Hoarseness Or Changing Voice: 5 people, 45.45%
- Oedema Peripheral (superficial swelling): 4 people, 36.36%
- Dyspnea (difficult or laboured breathing): 4 people, 36.36%
- Constipation: 3 people, 27.27%
- Pleural Effusion (water on the lungs): 3 people, 27.27%
- Fever: 3 people, 27.27%
- Neuropathy Peripheral (surface nerve damage): 3 people, 27.27%
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 45.45%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 45.45%
- Sleep Disorder: 2 people, 18.18%
- Ovarian Cancer (cancer of ovary): 2 people, 18.18%
- Oral Candidiasis (fungal infection of mouth): 2 people, 18.18%
- Muscle Spasms (muscle contraction): 2 people, 18.18%
- Migraine (headache): 2 people, 18.18%
- Enterobacter Sepsis (sepsis due to bacteria of the family enterobacteriaceae): 2 people, 18.18%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 18.18%
- Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 2 people, 18.18%
* Approximation only. Some reports may have incomplete information.
Do you take Clonidine and have Microangiopathy?
- Check whether Microangiopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Clonidine:
- Clonidine (65,645 reports)
Microangiopathy treatments and more:
- Microangiopathy (1,304 reports)
How severe was Microangiopathy and when was it recovered:
Expand to all the drugs that have ingredients of clonidine:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Clonidine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Microangiopathy:
- Microangiopathy (234 drugs)
Browse all the conditions that are associated with Microangiopathy:
- Microangiopathy (332 conditions)
Related publications that referenced our studies
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on clonidine (the active ingredients of Clonidine) and Clonidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Zenpep and Citalopram Hydrobromide - now
- Could Prezista cause Headache? - a second ago
- Could Klonopin cause Rash Pruritic? - 5 seconds ago
- Could Clobetasol Propionate cause Application Site Dryness? - 9 seconds ago
- Hiv Infection and Oxygen Saturation Decreased - 15 seconds ago
- Could Hydroxyzine cause Serotonin Syndrome? - 17 seconds ago
- Could Acth cause Injection Site Urticaria? - 17 seconds ago
- Could Vitamins cause Drug Level Increased? - 24 seconds ago
- Could Remeron cause Gait Abnormal? - 24 seconds ago
- Could Aciphex cause Lump In The Abdomen? - 24 seconds ago